Arteris, Inc. (NASDAQ:AIP – Get Free Report) Director Wayne C. Cantwell sold 15,000 shares of the firm’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $6.95, for a total value of $104,250.00. Following the transaction, the director now directly owns 243,198 shares of the company’s stock, valued at approximately $1,690,226.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Arteris Trading Up 1.5 %
AIP stock traded up $0.10 during mid-day trading on Tuesday, reaching $6.95. 149,970 shares of the stock traded hands, compared to its average volume of 181,523. The stock’s fifty day moving average is $7.85 and its 200-day moving average is $7.58. The company has a market cap of $272.86 million, a P/E ratio of -6.62 and a beta of 1.12. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 0.17. Arteris, Inc. has a 52-week low of $4.20 and a 52-week high of $9.54.
Arteris (NASDAQ:AIP – Get Free Report) last issued its quarterly earnings results on Thursday, August 1st. The company reported ($0.21) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.07). Arteris had a negative net margin of 68.37% and a negative return on equity of 274.66%. The firm had revenue of $14.58 million during the quarter, compared to analysts’ expectations of $13.68 million. During the same quarter last year, the company posted ($0.25) EPS. As a group, sell-side analysts expect that Arteris, Inc. will post -0.9 earnings per share for the current year.
Institutional Inflows and Outflows
Analyst Upgrades and Downgrades
A number of equities research analysts have weighed in on the stock. Jefferies Financial Group reissued a “hold” rating and issued a $9.00 price target (down from $11.00) on shares of Arteris in a report on Monday, May 13th. Westpark Capital restated a “buy” rating and set a $11.00 target price on shares of Arteris in a report on Wednesday, July 31st. Finally, Rosenblatt Securities restated a “buy” rating and issued a $15.00 price target on shares of Arteris in a research report on Monday, August 5th.
Read Our Latest Stock Analysis on Arteris
Arteris Company Profile
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Further Reading
- Five stocks we like better than Arteris
- Top Biotech Stocks: Exploring Innovation Opportunities
- Matador Resources Insiders Keep Buying Its Stock, Should You?
- Retail Stocks Investing, Explained
- Oracle Can Turn the Magnificent 7 Into 8: Here’s Why
- What is a SEC Filing?
- Palantir Stock Is Up 14% on S&P 500 News: Is It Time to Buy?
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.